Scientists from King’s College London have successfully applied a new technology that disarms one of the most potent weapons cancer cells use to weaken the effects of chemotherapy drugs.

A new study published in JAMA Network Open by the Harvey L. Neiman Health Policy Institute reveals poverty, environmental risks, housing issues, and physical inactivity are top-ranking community-level predictors of disparities in cancer screening, prevalence, and deaths across U.S. counties.

Atrial fibrillation (AFib) is a cardiac disorder in which the chambers of the heart beat rapidly and irregularly. It’s the most common type of arrhythmia and the leading cardiac cause of stroke.

Researchers from the University at Albany and NYU Grossman School of Medicine have found a way to block a key cellular pathway known to drive chronic inflammation and impaired wound healing in people with diabetes.

Spinal cord injury (SCI) remains a major unmet medical challenge, often resulting in permanent paralysis and disability with no effective treatments. Now, researchers at University of California San Diego School of Medicine have harnessed bioinformatics to fast-track the discovery of a promising new drug for SCI.

Deep brain stimulation (DBS) is a surgical procedure that entails the delivery of high-frequency electrical impulses to specific regions of the brain, via surgically implanted electrodes.

Findings point to promising drug that restores neuron balance and may slow disease progression